Kendall Park, NJ, United States of America

Elizabeth Gerig Rowley

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004-2021

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: **Elizabeth Gerig Rowley: Innovator in Opioid Receptor Modulation**

Introduction

Elizabeth Gerig Rowley is a notable inventor based in Kendall Park, NJ, who has made significant contributions to the field of neuroscience through her innovative work on opioid receptor modulation. With a total of four patents, her inventions reflect a commitment to addressing complex medical challenges, particularly in the realms of pain management and drug addiction.

Latest Patents

Rowley's latest patents focus on the development of allosteric modulators of the mu opioid receptor. These compounds belong to the class of amine-bearing heterocycles and serve as both positive and silent allosteric modulators of the mu opioid receptor. The implications of these compounds are profound, offering potential therapeutic avenues for treating pain, drug addiction, and various central nervous system disorders influenced by the activation of the mu opioid receptor. The methodologies for the synthesis and application of these modulating compounds are also part of the disclosures.

Career Highlights

Throughout her career, Elizabeth has worked with prominent organizations, contributing her expertise to both Chiromics, LLC and Bayer CropScience AG. Her experience in these companies has not only enriched her knowledge but also facilitated impactful advancements in the field of medical innovation.

Collaborations

Rowley has had the privilege of collaborating with esteemed colleagues, including George Theodoridis and Edward J Barron. These partnerships have likely fostered an environment of creativity and progress, driving forward the development of groundbreaking solutions in medical science.

Conclusion

In summary, Elizabeth Gerig Rowley's innovative contributions in the area of opioid receptor modulation stand out in the landscape of current medical research. With her patents paving the way for improved treatments for pain and addiction, her work exemplifies the transformative power of innovation in addressing critical healthcare issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…